Browsing CEMCAT - Articles científics by Title
Now showing items 77-96 of 106
-
Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis
(Lippincott Williams & Wilkins, 2021-10-19) -
SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry
(Lippincott Williams & Wilkins, 2021-06-24) -
Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum Disorder
(Wolters Kluwer Health, 2024-01) -
Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab
(Lippincott Williams & Wilkins, 2021-07) -
Specific Patterns of Immune Cell Dynamics May Explain the Early Onset and Prolonged Efficacy of Cladribine Tablets: A MAGNIFY-MS Substudy
(Lippincott Williams & Wilkins, 2023-01) -
Teriflunomide and Epstein–Barr virus in a Spanish multiple sclerosis cohort: in vivo antiviral activity and clinical response
(Frontiers Media, 2023-09-29) -
The OSCAR-MP Consensus Criteria for Quality Assessment of Retinal Optical Coherence Tomography Angiography
(Wolters Kluwer Health, 2023-11) -
The potential of serum neurofilament as biomarker for multiple sclerosis
(Oxford University Press, 2021-10) -
The state of multiple sclerosis: current insight into the patient/health care provider relationship, treatment challenges, and satisfaction
(Dove Medical Press, 2016-12-22) -
Therapeutic inertia in the management of neuromyelitis optica spectrum disorder
(Frontiers Media, 2024-02-21)